Tirzepatide
Dual GIP / GLP-1 receptor peptide · 39 amino acids
A synthetic 39-amino-acid peptide with dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor affinity. Supplied as a research material for in-vitro laboratory study only. Selected published literature involving this compound is listed under Studies below; those references are provided for scientific context and are not statements of effect.
- Cold-chain shipped
- Lot-specific COA
- Free shipping over $150.00
- 100% purity guarantee
All products sold by Atilis Peptides are intended strictly for in vitro laboratory research and development purposes. They are not drugs, supplements, food, or cosmetics and have not been approved by the FDA. They are not to be administered to humans or animals under any circumstance. By purchasing from Atilis Peptides you confirm you are a qualified researcher over 21 years of age and assume full responsibility for the safe handling, storage, and use of these compounds within an appropriate research setting.
Specifications
- Form
- Lyophilized powder
- Size
- 30 mg / vial
- Purity (HPLC)
- >99%
- Appearance
- White lyophilized powder
- Storage
- Refrigerate after reconstitution
- CAS no.
- 2023788-19-2
- Mol. formula
- C225H348N48O68
- Mol. weight
- 4813.45 g/mol
Studies
Selected peer-reviewed literature involving Tirzepatide. References are listed for scientific context only and do not describe or imply any effect of this product.
- 1Tirzepatide Once Weekly for the Treatment of ObesityN Engl J Med, 2022
- 2Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesN Engl J Med, 2021
Citations link to the corresponding record on PubMed (U.S. National Library of Medicine).
Shipping from 6718 Blackhorse Pike · Egg Harbor Township, NJ